Pain Therapeutics Announces First Quarter 2009 Financial Results

prior to approval. * As previously disd, regulatory responsibility for FDA approval of REMOXY was recently shifted to King Pharmaceuticals, Inc. King plans to meet with the FDA in mid-2009. This FDA meeting should provide a reliable context in which to...